Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18285548 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Maribavir for Prevention of CMV After Stem Cell Transplants
Condition: Cytomegalovirus Infection
Interventions: Drug: Maribavir;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.